Bio

Ana Gupte Ph.D is a Strategy, Finance and Innovation Leader and Principal Advisor with over two decades of experience in the field of Healthcare Services, Digital Health.and Therapeutics. She is passionate about strategy, innovation and policy trends in healthcare for improving cost, quality and access, and the public and private capital markets funding such innovation to market. She is also passionate about diversity and devotes much of her time to mentoring women and minority leaders in the field of healthcare. Her current efforts are focused on advising healthcare tech enabled services and digital health companies on go-to-market (GTM) strategy and build out of scalable service offerings, where she brings differentiated knowledge and network in the Payor, Provider, Pharma and MedTech end markets to bear as also the competitive landscape. She keenly monitors the private and publicly traded equity markets in healthcare across innovation and policy trends and investment opportunities. Ana is well recognized for her healthcare equity analyst coverage over a decade on Wall Street bookended by senior Corporate Strategy, Finance & Management Consulting roles. Most recently, she served as SVP, Chief Strategy & Innovation Officer at Florida Blue Cross Blue Shield & its parent GuideWell. Prior to the Street, she served as Managing Director Corporate Strategic Planning at Aetna, Inc, and also headed up the WorldWide Drug Development Strategy Department at Pfizer. She started her career in healthcare as a Management Consultant at McKinsey & Company. Her thought leadership on all things healthcare over 12 years of equity coverage in the firms of Sanford C. Bernstein, and SVB Securities (Leerink Partners) garnered multiple awards including Top 3 rankings by All America Institutional Investor and the FT StarMine Top Stock picker award. She has been a frequent contributor on CNBC, and widely quoted in media including the NY Times, WSJ, and Forbes. She has a B.S in Chemical Engineering from Bombay University, an M.S. and Ph.D in Bioengineering from the Pennsylvania State University and has graduated from the two year Executive Management program in Business Administration from the Wharton School of Business.